Resultado da Busca
22 de mar. de 2019 · de Ferranti et al CV Risk Reduction in High-Risk Pediatric Patients e604 March 26, 2019 Circulation. 2019;139:e603–e634. DOI: 10.1161/CIR.0000000000000618 CIIC AM D IDI on pathophysiology and epidemiology. The overall ap-proach of risk stratification and preferential use of phar-macotherapy to reduce CVD risk in the highest-risk indi-
author = "Golden, {Neville H.} and Marcie Schneider and Christine Wood and Stephen Daniels and Steven Abrams and Mark Corkins and {De Ferranti}, Sarah and Magge, {Sheela N.} and Sarah Schwarzenberg and Jeff Critch and Van Hubbard and Kelley Scanlon and Valery Soto and Debra Burrowes and Tamar Haro and Braverman, {Paula K.} and William Adelman and Alderman, {Elizabeth M.} and Breuner, {Cora C ...
Sarah D. de Ferranti's 231 research works with 43,062 citations and 8,173 reads, including: International Atherosclerosis Society guidance for implementing best practice in the care of familial ...
La tormenta perfecta: obesidad, disfunción del adipocito y consecuencias metabólicas§. Sarah de Ferranti*, Dariush Mozaffarian** Traducción: Dra. Martha A. Sánchez Rodríguez. RESUMEN. Antecedentes: La apreciación de la cercanía entre la obesi-dad y la enfermedad se ha incrementado dada la elevación de la prevalencia de obesidad en ...
Abstract. Purpose: Heart disease is the number one cause of death in women. Little is known about how adolescent and young adult women perceive their risk of heart disease. Methods: We conducted eight online, semistructured focus groups with 35 young women aged 15-24 years recruited from two primary care practices in Boston, MA.
Sarah De Ferranti, MD is a Pediatric Cardiologist in Boston, MA. Sarah De Ferranti was board certified by the American Board of Pediatrics. Sarah De Ferranti, MD does not participate in Zocdoc to offer online booking at this time.
30 de abr. de 2021 · SES and SVI were similar between patients with MIS-C and coronavirus disease 2019. In multivariable analysis, lowest SES quartile (odds ratio 2.2 [95% confidence interval 1.1–4.4]), highest SVI quartile (odds ratio 2.8 [95% confidence interval 1.5–5.1]), and racial and/or ethnic minority background were associated with MIS-C diagnosis.
